Belzutifan - HY-125840

Nur noch %1 verfügbar
Catalog #
HY-125840
Ab 196,00 €
Belzutifan (PT2977) is an orally active and selective HIF-2α inhibitor with an IC50 of 9 nM. Belzutifan, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile. Belzutifan is a potential treatment for clear cell renal cell carcinoma (ccRCC)[1].
Weitere Informationen
Datasheet URL http://file.medchemexpress.com/batch_PDF/HY-125840/Belzutifan-DataSheet-MedChemExpress.pdf
Shipping Blue Ice
Application Cancer-programmed cell death
Alternative Names PT2977; MK-6482
CAS 1672668-24-4
Storage -20°C (Powder, stored under nitrogen)
MWT 383.34
Solubility Acetone : 50 mg/mL (ultrasonic)|DMSO : 50 mg/mL (ultrasonic)|H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C)
Clinical Information Launched
Target HIF/HIF Prolyl-Hydroxylase
Applications
Application: Cancer-programmed cell death

Newsletter
abonnieren

15% Rabatt

erhalten